... Study findings showed that low doses could help relieve symptoms of treatment-resistant depression within hours.In 2019, the FDA approved esketamine (Spravato), a nasal spray based on ketamine, for people with depression that doesn’t improve with standard treatments.Ketamine’s Effects on the BrainKetamine works differently from traditional antidepressants ...
... Study findings showed that low doses could help relieve symptoms of treatment-resistant depression within hours.In 2019, the FDA approved esketamine (Spravato), a nasal spray based on ketamine, for people with depression that doesn’t improve with standard treatments.Ketamine’s Effects on the BrainKetamine works differently from traditional antidepressants ...
... Due to potential side effects — including dissociation (out-of-body experience), high blood pressure, blurred vision, nausea, and vomiting — and the risk of misuse, ketamine infusions are usually given under direct physician supervision in an outpatient clinic setting.Ketamine-Based TreatmentsIn recent years, the FDA has approved esketamine (Spravato ...
... Due to potential side effects — including dissociation (out-of-body experience), high blood pressure, blurred vision, nausea, and vomiting — and the risk of misuse, ketamine infusions are usually given under direct physician supervision in an outpatient clinic setting.Ketamine-Based TreatmentsIn recent years, the FDA has approved esketamine (Spravato ...
Join